{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-032062","form_type":"8-K","ticker":"VBIO","cik":"0001787740","company_name":"Valion Bio, Inc.","filed_at":"2023-07-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.245697+00:00","generated_at":"2026-06-13T12:03:52.153185+00:00","sec_items":["5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Tivic Health amends bylaws to adopt universal proxy rules and lower quorum threshold","bullets":["Amended Bylaws to incorporate SEC Rule 14a-19 universal proxy requirements.","Reduced quorum for stockholder meetings to one-third of outstanding shares entitled to vote.","Amendment effective July 5, 2023; stockholder approval not required under Bylaws."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-032062","json":"https://secwatch.observer/filing/0000950170-23-032062.json","markdown":"https://secwatch.observer/filing/0000950170-23-032062.md","text":"https://secwatch.observer/filing/0000950170-23-032062.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1787740/000095017023032062/0000950170-23-032062-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1787740/000095017023032062/tivc-20230705.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T12:03:52.153185+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"94b3295431bd88c0088074c205c19e2fa676486f","claim":"Valion Bio, Inc.: Amended Bylaws to incorporate Rule 14a-19 requirements and reduce quorum threshold to one-third (effective 2023-07-05).","evidence_excerpt":"On July 5, 2023, Tivic Health Systems, Inc. (the “Company”) amended its Amended and Restated Bylaws (the “Bylaws”) to (i) revise Article II, Section 2.5 of the Bylaws to incorporate those requirements set forth in Rule 14a-19 of the Securities Exchange Act of 1934, as amended, as recently implemented by the SEC; and (ii) to revise Article II, Section 2.8 of the Bylaws to decrease the quorum threshold necessary to conduct business at stockholder meetings of the Company to one-third of the capital stock issued and outstanding and entitled to vote at the meeting.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1787740/000095017023032062/0000950170-23-032062-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2023-07-05"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}